OpenAI just published Keeping Patients First, a 20-page policy blueprint for AI in U.S. healthcare. It covers data portability, clinical documentation burden, access disparities, and regulatory sandboxes. It's thoughtful, well-sourced, and positions OpenAI as a serious policy actor in a space it clearly wants to own.
It also says absolutely nothing about prior authorization.
For RCM professionals, that silence is worth examining. But there's plenty in what the document does say that matters for where the revenue cycle is heading.
The blueprint frames U.S. healthcare as a system in structural distress: expensive, hard to navigate, and increasingly shifting toward reactive "sick care." OpenAI's pitch is that AI can help patients reclaim agency and reduce clinician burnout — without pretending AI fixes hospital closures or care deserts.
Three policy pillars anchor the document:
The numbers OpenAI cites to support this framing are striking:
Physician adoption doubling in three years isn't a trend — it's a structural shift. The question for RCM is whether that adoption is being captured in revenue-impacting workflows or just in documentation shortcuts.
Here's what's notable about this blueprint: it's comprehensive on patient-facing and clinician-facing AI, and almost entirely silent on payer-facing AI.
Prior authorization — currently the most litigated, most legislated, and most operationally disruptive AI application in healthcare — doesn't appear. Utilization management, claims adjudication, and AI-driven denial engines are absent. In a document explicitly about AI policy in healthcare, that's not an oversight. It's a choice.
OpenAI does land one pointed line: AI benefits should be "broadly shared with patients and clinicians rather than being concentrated among large health systems, insurers, or pharmaceutical companies." That's a clean shot at the UHC/Humana AI denial infrastructure — even if the document won't say it directly.
Why does this matter for RCM teams? Because the prior auth AI policy fight is happening in a vacuum that industry blueprints like this one aren't filling. CMS finalized prior auth transparency rules for Medicare Advantage effective 2026. Congress has pushed PRIOR Act legislation in multiple sessions. States are moving independently. OpenAI's policy team is focused elsewhere.
That means the regulatory framework governing payer AI — the thing that directly drives your denial rate — is being shaped by CMS rulemaking and litigation, not by the AI companies themselves. Know that going into every payer contract negotiation.
OpenAI explicitly calls for enforcement of the 21st Century Cures Act information blocking rule — and for extending it to providers not currently covered (some labs, pharmacies, specialty providers). For RCM, this matters: when patients can actually move their records, referral workflows get cleaner, pre-auth documentation gets faster, and the documentation burden that drives claim delays gets lighter.
The blueprint also pushes for TEFCA acceleration and IAL2 identity-proofing standards. If TEFCA actually scales, real-time eligibility verification and prior auth data exchange become significantly easier. Don't count on it in 2026, but build toward it.
The blueprint argues clinicians should be able to use AI for documentation, transcription, and summarization without burdensome disclosure mandates. That's a win for ambient AI platforms like Nabla, Suki, and the EHR-native tools (Epic Ambient, Oracle's ambient offering). It's also directly relevant to RCM: cleaner, faster clinical documentation reduces the downstream coding burden and closes the gap between service delivery and billable claim.
AdventHealth's numbers in the report are worth noting: ChatGPT reduced post-discharge call documentation from 10–20 minutes to ~5 minutes, increasing outreach capacity from 8 to 12–14 calls per day. That's a 50–75% productivity lift on a workflow that directly affects patient satisfaction scores and readmission-linked revenue. Scale that across a health system's RCM team and it's meaningful.
OpenAI recommends establishing AI affordability pilots in Medicaid, Medicare, and public hospitals — with public reporting on outcomes. If those pilots move forward, they'll generate comparative effectiveness data on AI RCM tools in government payer environments. For practices and health systems with heavy Medicaid mix, that data will matter more than any vendor pitch deck.
A policy blueprint from OpenAI doesn't change your AR days tomorrow. But here's the practical read:
"The benefits of AI in healthcare should be broadly shared with patients and the clinicians who serve them, rather than being concentrated among large health systems, insurers, or pharmaceutical companies." — OpenAI, Keeping Patients First, April 2026
That sentence was written about patients. Read it again from the perspective of independent practices and smaller health systems watching UHC's AI denial rate climb. It lands differently.
RevCycleAI tracks payor policy changes, prior auth updates, and AI-driven denial trends — published within 24 hours of every major move.
Explore Pro →